Comparison of two fludarabine-based reduced-intensity conditioning regimens in elderly or infirm patients with myeloid malignancies treated with allogeneic hematopoietic stem cell transplantation

被引:0
|
作者
Czyz, A. [1 ]
Nasilowska-Adamska, B. [2 ]
Lojko-Dankowska, A. [1 ]
Matuszak, M. [1 ]
Bembnista, E. [1 ]
Kozlowska-Skrzypczak, M. [1 ]
Halaburda, K. [2 ]
Warzocha, K. [2 ]
Komarnicki, M. [1 ]
机构
[1] Poznan Univ Med Sci, Poznan, Poland
[2] Inst Hematol & Blood Transfus, Warsaw, Poland
关键词
D O I
暂无
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
P210
引用
收藏
页码:S222 / S222
页数:1
相关论文
共 50 条
  • [1] Reduced-intensity conditioning with fludarabine and busulfan for allogeneic hematopoietic cell transplantation in elderly or infirm patients with advanced myeloid malignancies
    Schneidawind, Dominik
    Federmann, Birgit
    Buechele, Corina
    Helwig, Andrea
    Schmohl, Joerg
    Vogel, Wichard
    Faul, Christoph
    Kanz, Lothar
    Bethge, Wolfgang A.
    ANNALS OF HEMATOLOGY, 2016, 95 (01) : 115 - 124
  • [2] Reduced-intensity conditioning with fludarabine and busulfan for allogeneic hematopoietic cell transplantation in elderly or infirm patients with advanced myeloid malignancies
    Dominik Schneidawind
    Birgit Federmann
    Corina Buechele
    Andrea Helwig
    Jörg Schmohl
    Wichard Vogel
    Christoph Faul
    Lothar Kanz
    Wolfgang A. Bethge
    Annals of Hematology, 2016, 95 : 115 - 124
  • [3] Feasibility of allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning regimens for refractory myeloid malignancies.
    Hamaki, T
    Kami, M
    Kim, SW
    Yamamoto, R
    Imataki, O
    Suyama, H
    Arima, F
    Nakai, K
    Saito, T
    Kanda, Y
    Makimoto, A
    Tanosaki, R
    Mineishi, S
    Takaue, Y
    BLOOD, 2002, 100 (11) : 851A - 851A
  • [4] Fludarabine-based reduced intensity conditioning regimens for allogeneic hematopoietic stem cell transplantation in patients with aplastic anemia and fungal infections
    George, Biju
    Mathews, Vikram
    Viswabandya, Auro
    Srivastava, Alok
    Chandy, Mammen
    CLINICAL TRANSPLANTATION, 2009, 23 (02) : 228 - 232
  • [5] Reduced-intensity conditioning with treosulfan and fludarabine for allogeneic hematopoietic stem cell transplantation
    Nihtinen, A
    Volin, L
    Juvonen, E
    Ruutu, T
    BONE MARROW TRANSPLANTATION, 2003, 31 : S159 - S159
  • [6] Allogeneic stem cell transplantation for patients with advanced hematological malignancies: Comparison of fludarabine-based reduced intensity conditioning versus myeloablative conditioning
    Kim, Inho
    Lee, Kyung-Hun
    Choi, Yunhee
    Keam, Bhumsuk
    Koo, Nam Hee
    Yoon, Sung-Soo
    Yoo, Keun-Young
    Park, Seonyang
    Kim, Byoung Kock
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2007, 22 (02) : 227 - 234
  • [7] FLUDARABINE-BASED REDUCED INTENSITY CONDITIONING REGIMENS FOR HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PEDIATRIC PATIENTS WITH PRIMARY IMMUNODEFICIENCY
    Hamidieh, A. A.
    Pourpak, Z.
    Alimoghaddam, K.
    Fazlollahi, M. R.
    Jalili, M.
    Movahedi, M.
    Moin, M.
    Ghavamzadeh, A.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (02) : S182 - S182
  • [8] Fludarabine and treosulfan compared with other reduced-intensity conditioning regimens for allogeneic stem cell transplantation in patients with lymphoid malignancies
    Yerushalmi, R.
    Shem-Tov, N.
    Danylesko, I.
    Avigdor, A.
    Nagler, A.
    Shinnoni, A.
    BONE MARROW TRANSPLANTATION, 2015, 50 (12) : 1526 - 1535
  • [9] Fludarabine and treosulfan compared with other reduced-intensity conditioning regimens for allogeneic stem cell transplantation in patients with lymphoid malignancies
    R Yerushalmi
    N Shem-Tov
    I Danylesko
    A Avigdor
    A Nagler
    A Shimoni
    Bone Marrow Transplantation, 2015, 50 : 1526 - 1535
  • [10] Better Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation with Reduced-Intensity Conditioning in Elderly Patients with Hematological Malignancies
    Zhao, Yongqiang
    Song, Yanzhi
    Yang, Fan
    Li, Feifei
    Yang, Dongfang
    Wu, Tong
    BLOOD, 2021, 138